FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug
Confidence boost for AI virtual cells for novel target discovery
Anti-fibrotic drug could be repurposed to control cell communication
Positive data from oral therapy designed to improve muscle function and body composition
Stargardt disease targeted with $135m SpliceBio financing
Base to Base biotech podcast 13: Syngene commits to US market, and Nimbus Therapeutics on computational chemistry
Base to Base biotech podcast 12: CLS boosts drug discovery capabilities and Sitryx – pioneers in immunometabolism
Base to Base biotech podcast 11: Turning cancer into a chronic disease, and a different way to draw blood
Base to Base biotech podcast 10: 3D printing human organs and early detection of ovarian cancer
Base to Base biotech podcast 9: Microbiotica, 1Cell.Ai and Tessellate Bio at AACR
Base to Base biotech podcast 8: ‘Photoshop for proteins’ and improving operations
Base to Base biotech podcast 7: The DSCSA deadline and the first Nanobody